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Focal Upper Limb 
Mononeuropathies in Patients 
with Diabetes Mellitus
Tayir Alon and Vera Bril
Abstract
In this chapter, we describe the prevalence, diagnostic methods, and treatment 
efficacy of compressive neuropathies of the median and the ulnar nerves in patients 
with diabetes mellitus (DM). Median neuropathy at the wrist is found in up to one-
third of patients with DM, when demonstrated electrophysiologically, but is symp-
tomatic as carpal tunnel syndrome (CTS) in a smaller proportion of these patients. 
It is clear that diabetes increases the risk of having clinical CTS. Diagnosis of CTS 
using nerve conduction studies is difficult in patients with DM and diabetic sen-
sorimotor polyneuropathy (DSP) as median nerve conduction studies are affected 
predominantly by the diabetes state. We will discuss different electrodiagnostic and 
ultrasonography techniques for diagnosis and the outcomes of carpal tunnel release 
decompressive surgery in this special patient population. It is controversial whether 
DM is a risk factor for cubital tunnel syndrome or ulnar neuropathy at the elbow 
(UNE) or at the wrist (UNW). In this chapter, we will review the ultrasonographic 
and electrophysiological diagnostic techniques used in UNE and UNW and the 
efficacy of cubital tunnel release in DM patients.
Keywords: mononeuropathy, diabetes mellitus, carpal tunnel syndrome,  
nerve compression, diabetic sensorimotor polyneuropathy, median nerve, ulnar 
nerve, carpal tunnel syndrome, cubital tunnel syndrome
1.  What causes the increased vulnerability to entrapment neuropathies 
in patients with DM
Entrapment neuropathies are more prevalent among patients with DM, and 
carpal tunnel syndrome (CTS) can guide a better understanding of the patho-
physiology of entrapment neuropathies in this patient population. CTS is the most 
commonly studied entrapment syndrome and changes in the small arteries, such 
as vascular hypertrophy and intimal thickening, and noninflammatory fibroses of 
connective tissue are key pathologic features as discussed earlier in this book. In 
patients with DM, the reasons for the higher susceptibility to entrapment neuropa-
thies are likely the combination of increased vulnerability of the nerves to compres-
sion arising from underlying diffuse DM-related nerve fiber injury and the presence 
of altered connective tissue structures within the carpal tunnel causing additional 
compression [1]. These two mechanisms are most likely relevant to all entrapment 
neuropathies in DM. Axonal, metabolic, and structural changes in DM that can 
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lead to higher susceptibility to external injury are well-known. Less information 
on altered connective tissue structure in areas of nerve compression is available 
in this patient population. Deger et al. found a statistically significant increase in 
neoangiogenesis in subsynovial connective tissue in DM CTS cases, correlating with 
greater expression of vascular endothelial growth factor (VEGF), in subsynovial 
connective tissue in DM than what is present in CTS in patients without DM [2, 3]. 
These findings are consistent with the findings of Tekin et al., showing DM CTS 
patients, when compared with non-DM CTS patients, have higher rates of synovial 
edema and vascular proliferation and increased vascular wall thickness [4]. Thus 
the increased neovascularization, arising from a proposed ischemia-reperfusion 
mechanism, and more apparent in patients with DM, impinges the tissue compart-
ment space within the carpal tunnel. In their recently published review, Sharma and 
Jaggi summarize the current knowledge regarding the role of transforming growth 
factor (TGF-β), VEGF, and interleukins in the subsynovial connective tissue in CTS 
patients, with and without diabetes [5].
2.  Median compressive neuropathy at the wrist in patients with diabetes 
mellitus (DM)
The high prevalence of DM among patients with clinical CTS was first noted in 
1962 by Blodgett et al. who reported DM in 59/915 or 6.4% of consecutive patients 
diagnosed with CTS [6]. A higher prevalence of DM among patients with CTS was 
described in 1972 by Phalen, who reported DM in 14.6% or in 56/384 consecutive 
patients diagnosed with CTS [7]. Subsequent studies demonstrated a similar preva-
lence with the calculated odds ratio (OR) of 3.02 for CTS in DM [8, 9]. The risk of CTS 
is further increased in DM patients with neuropathic symptoms, as shown by Perkins 
et al., who found a similar frequency of clinical CTS in 14% of nonneuropathic DM 
subjects, increasing to 30% in those with diabetic sensorimotor polyneuropathy 
(DSP) of varying severity [10]. This prospective cohort study evaluated clinical CTS, 
defined rigorously, across a broad spectrum of DSP patients (Table 1). Pourmemari 
and Shiri performed a meta-analysis including over 90,000 subjects and examined 
DM as a risk factor for CTS. They found the association to be more modest with an 
unadjusted OR estimate of about 2 and less when controlling for potential confound-
ing factors with a pooled estimate OR was 1.59 [11, 12]. This outcome may be related to 
varying definitions of CTS within different studies included in the meta-analysis.
Comi et al. examined the prevalence of median neuropathy in patients with 
DM using electrophysiological studies, but not symptoms and signs of CTS. 
Paresthesiae in hands or marked preponderance of sensory symptoms in the hands
Nocturnal hand symptoms awakening the patient
Symptoms precipitated by activities such as holding a newspaper or driving a car and relieved by hand 
shaking
Predilection for radial digits
Weak thenar muscles
Upper limb sensory loss solely within the distribution of the median nerve
4/6 criteria required to diagnose CTS in those with DM with or without DSP [10]
Electrodiagnostic criteria for CTS unreliable in the presence of DM [10]
Table 1. 
Clinical criteria for the diagnosis of carpal tunnel syndrome in diabetes patients.
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11.2% showed electrophysiology indicating focal median neuropathy. The 
prevalence was higher (16.1%) among patients with DSP [13]. Other studies 
have shown even higher rates, up to 23%, of asymptomatic median compressive 
neuropathy at the wrist in patients with DM [14]. The issue with this approach 
is that CTS is a clinical diagnosis, and the Perkins study showed that electro-
physiological changes at the carpal tunnel are related to DSP and not indicative 
of the presence of CTS [10]. All of these studies indicate that although median 
neuropathy at the wrist is relatively common in patients with DM when tested 
by nerve conduction studies, clinical CTS is not found in a similar proportion. 
Symptomatic CTS was described in 9% of DM subjects in an early study [15], 
and the lifetime risk of symptomatic CTS in type 1 diabetes was calculated more 
recently to be as high as 85% by Singh et al. [16].
2.1  Electrophysiologic and ultrasonographic diagnostic techniques used in 
median compressive neuropathy at the wrist in patients with DM
DSP symptoms might mimic those of CTS in clinical practice. Nonetheless, clear 
symptoms for a diagnosis of CTS can be established even in those with advanced 
DSP [10]. Establishing the diagnosis of CTS based solely on electrophysiological 
diagnostic criteria is unreliable in DM patients, since the changes in electrophysi-
ological parameters are due to DSP rather than CTS [10]. Various electrophysiologi-
cal parameters are thought to distinguish CTS from DSP in subjects with DM, but 
none were found to be different in those with and without CTS in a population of 
subjects with DM [10]. Parameters such as median nerve distal motor or sensory 
latency, comparison of ratios of median (ulnar latencies or amplitudes or sensory 
conduction velocities), and others failed to differentiate those patients who had 
clinical CTS from those who did not in subjects with DM [10]. Consequently, in 
subjects with DM, it is prudent to be cautious in attributing changes in electrophysi-
ological parameters to CTS rather than DM with or without DSP.
There have been attempts to establish electrodiagnostic methods that might 
distinguish CTS from DSP but doubt about the results which arise from the Perkins 
study [10]. For example, the median nerve distal motor latency or the median nerve 
sensory distal onset latency when stimulating at the palm or at the wrist crease has 
been reported to show differences between DM patients with CTS and idiopathic 
CTS in a small study [17], but those same parameters were not reliable in larger 
studies [10, 18]. Additional studies have reported other parameters that may be 
useful in diagnosis such as the median-radial sensory latency difference from the 
thumb, which showed 94% sensitivity in one study [19], and for a cutoff of 0.55, 
82% sensitivity and 80% specificity in another study [18]. As the ulnar nerve is 
also susceptible to entrapment, a comparison of median nerve parameters to radial 
nerve parameters was thought to be preferable. Other studies have suggested using 
the median-ulnar sensory latency difference measured from the ring finger with 
86% sensitivity in one study [19], and for a cutoff of 0.35, 90% sensitivity and 85% 
specificity in another study [18], although this sensory latency difference could not 
identify those with CTS in a larger study [10]. The lumbrical-interosseous latency 
difference was significantly different between CTS patients with and without DM, 
with sensitivity of up to 88.4% in two studies [17, 20], and for a cutoff of 1 ms had 
78% sensitivity in another study [21].
Small studies have examined the feasibility of using ultrasonography to dis-
tinguish CTS with DM cases from DSP alone. Kim et al. found that all the cross-
sectional areas (CSA) of the median nerve were larger in DSP patients compared 
with healthy controls, and the CSA of the median nerve at the wrist revealed 
no significant differences among DSP patients with and without CTS; however, 
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patients with CTS (with and without DM) had larger CSAs at the wrist and a 
higher wrist/forearm ratio compared with DSP patients. The cutoff value for the 
CSA at the wrist that yielded the highest sensitivity and specificity was 11.6 mm 
[22]. A smaller study found no ultrasound measurement (distal median CSA, 
wrist-forearm ratio, wrist-forearm difference) reached significance to detect CTS 
in patients with DSP [17].
2.2 Treatment efficacy for CTS in patients with DM
The outcome of open decompression of the median nerve by sectioning the 
carpal transverse ligament in DM patients has been evaluated in many studies. 
Several studies, with a post-procedure follow-up of up to 2 years, showed similar 
beneficial outcomes, in nerve conduction studies and symptoms, for patients with 
and without DM [23–29]. Some studies found that electrodiagnostic findings and 
assessment of symptoms and clinical signs improved significantly in both DM 
patients and in non-DM patients but that the improvement was less in the diabetic 
group [30–33]. Zhang et al. demonstrated an association of DM with an increased 
risk for secondary surgery following carpal tunnel decompression. They tested a 
total of 904 patients with and without DM, for a median follow-up length of less 
than a year [34]. Gulabi et al. compared the symptomatic outcome at 6 months 
and 10 years after decompression of 27 patients with DM and 42 patients with 
idiopathic CTS. They found that at 6 months, the outcomes were similar for the 
DM and non-DM groups, but at 10 years the DM group had poor outcomes possibly 
due to progression of DSP in the DM group [35]. Recently published results of a 
randomized controlled prospective study comparing the outcome of endoscopic 
carpal tunnel release versus open carpal tunnel release in DM patients suggest that 
the endoscopic approach is more beneficial for patients with diabetes. In this study, 
the patients who underwent endoscopic carpal tunnel release had better relief of 
symptoms and better function scores, less pillar pain and tenderness at 12 weeks 
after surgery, faster regain of grip and pinching functions, significantly faster 
return to work and significant improvement in wound healing, as well as reduction 
in wound infection and complications [36].
The evidence to date indicates that surgery in DM patients with CTS leads to 
an improvement in symptoms and signs of CTS that is very similar to non-DM 
patients with CTS. Given this background, it is reasonable to offer surgical therapy 
to DM patients with CTS when conservative treatments have failed, as is the case for 
idiopathic CTS, i.e., in those without DM.
3. Compressive ulnar neuropathy at the elbow in patients with DM
There is controversy over whether or not cubital tunnel syndrome is more 
common in those with DM. Stamboulis et al. found 12.2% of patients with cubital 
tunnel syndrome had DM [37]. In other studies, the prevalence of DM was the same 
in patients with cubital tunnel syndrome as in the general population, i.e., 6% in 
both groups, when the diagnosis of cubital tunnel syndrome was established on the 
combination of symptoms, objective clinical findings, and electrodiagnostic tests 
[38], and the severity of symptoms was also similar between those with and without 
DM [39]. In a case-control study, including only patients who had undergone ulnar 
nerve decompression, DM was not found to be a risk factor for ulnar neuropathy 
at the elbow [40]. The question of whether DM is a risk factor for cubital tunnel 
syndrome remains uncertain.
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3.1  Electrophysiologic and ultrasonographic diagnostic techniques used in 
compressive ulnar neuropathy at the elbow in patients with DM
Rota et al. tested DM patients for ulnar neuropathy at the elbow irrespec-
tive of clinical symptoms and found that 34% had electrodiagnostic features 
of ulnar dysfunction due to chronic compression at the elbow. Most of the 
patients with neurophysiological abnormalities were asymptomatic, and only 
6% had sensory symptoms and showed clinical signs of cubital tunnel syn-
drome [41].
It has been demonstrated in large cohorts that sensory nerve conduction 
velocity and amplitudes of sensory nerve action potentials are markedly lower in 
DM patients than in healthy controls, even more so in DM patients with known 
DSP [38, 42–45]. As asymptomatic ulnar nerve entrapment at the elbow (UNE) is 
relatively common among patients with DM, possibly due to the underlying DSP 
similar to CTS, when the diagnosis of cubital tunnel syndrome in patients with 
DM with or without DSP is in question, we rely mainly on changes in the motor 
conduction electrophysiologic parameters. Schady et al. studied 20 DM patients 
with cubital tunnel syndrome, demonstrated by hand wasting and weakness. All 
patients also had signs of DSP in the lower limbs. The nerve conduction studies 
in this cohort showed markedly reduced ulnar nerve compound muscle action 
potential (CMAP) amplitudes with a mean value of 1.2 versus 7.4 mV in controls 
and also reduced ulnar/median CMAP amplitude ratios. Less sensitive than the 
CMAP amplitudes was the ulnar nerve motor conduction velocity. This was 
disproportionately slowed across the elbow segment in only 8 of 34 affected ulnar 
nerves [43].
Only two studies have used ultrasonography for the diagnosis of ulnar compres-
sive neuropathy at the elbow in patients with DM. Kang et al. had demonstrated 
that the cross-sectional area (CSA) of the ulnar nerve at the cubital tunnel outlet 
was significantly greater in patients with DSP than in healthy controls, with no cor-
relation to nerve conduction study results [46]. It is possible that the larger CSA is 
a marker of DM and not specific for DSP or of ulnar compressive neuropathy at the 
elbow in patients with DM, as might be inferred from the second study. Chen et al. 
tested DM patients with and without confirmed DSP. They found that CSA of the 
ulnar nerve at the cubital tunnel outlet was greater in DM patients than that in the 
healthy control group, yet no difference was detected in the CSA of the ulnar nerve 
between DM patient with and without DSP [47]. These studies found no correlation 
between the cubital tunnel syndrome and the CSA or even between asymptomatic 
UNE and the CSA.
3.2  Treatment efficacy for ulnar compressive neuropathy at the elbow in patients 
with DM
A recent US national database review of more than 15,000 patients who under-
went ulnar nerve decompression at the cubital tunnel found a low incidence of 
failure of cubital tunnel release requiring ipsilateral revision, but the presence of 
DM was an independent risk factor for revision with an adjusted odds ratio of 1.27 
[48]. The presence of DM did not increase the risk for infection following cubital 
tunnel release [49]. Other smaller studies have found that DM is not associated 
with a poor surgical result, either clinically or electrophysiologically [50], or with 
a greater likelihood of revision surgery [51–53]. When satisfaction with treatment 
was assessed, having DM was not associated with a higher likelihood of dissatisfac-
tion with treatment [54].
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4.  Ulnar compressive neuropathy at the wrist in patients with diabetes 
mellitus (DM)
Ulnar entrapment at the wrist is far less common, and thus less studied, than 
ulnar nerve entrapment at the elbow. The prevalence of DM among patients  
with ulnar tunnel syndrome at the wrist is yet to be determined, as no large-scale 
study has assessed the presence of this potential entrapment. In fact, the only 
relevant data comes from a single retrospective study of 31 patients who had an 
ulnar nerve palsy treated by ulnar tunnel (Guyon’s canal) release, and 6 patients or 
19% had DM [55].
4.1 Electrophysiologic and ultrasonographic diagnostic techniques used in ulnar 
compressive neuropathy at the wrist in patients with DM
The diagnosis of ulnar tunnel syndrome at the wrist is routinely based on the 
motor nerve conduction study parameters. Rota et al. tested DM patients for ulnar 
neuropathy at the wrist, and their electrodiagnostic study demonstrated relevant 
neurophysiological abnormalities in 11% of the patients, all of whom had DSP 
as well. The paper does not state how many of the patients presenting with these 
electrophysiological abnormalities were symptomatic [41].
There is a single paper regarding the use of ultrasonography for the diagnosis 
of ulnar compressive neuropathy at the wrist in patients with DM. Chen et al., who 
tested DM patients with and without confirmed DSP, showed that the CSA of the 
ulnar nerve at Guyon’s canal was greater in DM patients than in the healthy control 
group, yet no difference was detected in the CSA of ulnar nerves between DM 
patients with and without DSP. No potential relationship to clinical signs or symp-
toms of ulnar tunnel syndrome was examined in this study [47].
5. Summary
Upper limb mononeuropathies are common in patients with DM with the most 
common being CTS. The diagnosis of CTS in DM is a clinical diagnosis as the elec-
trophysiologic and ultrasonographic parameters do not reliably distinguish between 
CTS and DSP. Treatment can be highly effective in CTS patients with DM whether 
or not DSP is present. Asymptomatic ulnar nerve electrophysiological abnormali-
ties are common in DM, but it is unclear if clinical entrapment syndromes at the 
elbow are more common or not. The success of surgical decompression of the ulnar 
nerve at the elbow in those with DM is similar to that in non-DM patients. Ulnar 
nerve entrapment at the wrist is infrequent, and data on diagnosis and treatment is 
limited or unavailable.
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